Business Context and Reporting Period
This Form 6-K filing by Innate Pharma S.A., a foreign private issuer, covers the month of November 2021. The report, dated November 16, 2021, serves to incorporate a press release (Exhibit 99.1) by reference into the company's registration statement on Form F-3. The filing was signed by Mondher Mahjoubi, Chairman of the Executive Board and Chief Executive Officer.
Key Financial Metrics
The provided filing text does not contain specific financial data. It is a procedural document referencing an external press release. Consequently, values for revenue, profit, cash flow, margins, debt, and liquidity are not present in this text.
Material Changes
The filing text does not disclose specific material changes in financial position or operations. It indicates that a press release was issued on November 16, 2021, but the content of that release is not included in the provided text.
Guidance, Outlook, and Risks
No guidance, outlook, management commentary, risks, contingencies, or unusual items are detailed in the provided text. The document solely confirms the submission of a press release for incorporation by reference.
Investor Verification Checklist
- Review the full text of the press release dated November 16, 2021 (Exhibit 99.1) to understand the specific corporate event or announcement.
- Verify the details of the Form F-3 registration statement (File No. 333-252074) to understand the context of the incorporation by reference.
- Check subsequent filings for any updates or superseding information regarding the November 2021 announcement.